Kaplan-Meier curves for DOR, PFS, EFS, and OS in the liso-cel–treated efficacy analysis set. (A) Duration of response; (B) progression-free survival; (C) event-free survival; (D) overall survival. Data on Kaplan-Meier curves are expressed as median (95% CI). Crosses denote censored patients. ∗Reverse Kaplan-Meier method was used to obtain median follow-up and its 95% CIs. †OS data include data from the long-term follow-up study. PD, progressive disease; PR, partial response; SD, stable disease.